Ginkgo Bioworks is a synthetic biology company. They went public on the NYSE on Sept 17, 2021, under the ticker symbol ‘DNA’. Ginkgo designs microorganisms for producing materials and medicines, waste treatment, and other applications.
With a Mergeflow account, you can explore technologies, companies, R&D and markets—beyond the example above.
No credit card, no software to install. Trial ends automatically after 14 days.